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Introduction: Recurrent bleeding and associated pain are critical components in the 
management of bleeding disorders, yet scant data describe perceptions of pain in this 
patient population.
Objective: This study assessed perceptions of pain and pain management in adoles-
cents and young adults (AYAs) with haemophilia or von Willebrand disease (VWD) to 
determine agreement/disagreement between patients, caregivers and health care 
providers.
Methods: Using an online questionnaire, AYA patients (N=89), their caregivers (N=77), 
and providers (N=54) reported on pain perception, pain treatment and pain control. 
Acute and chronic pain was measured in patients via the Faces Pain Scale–Revised 
(FPS- R). Questionnaires queried about pharmacologic and non- pharmacologic pain 
management methods and how well providers and caregivers helped to manage pain.
Results: Poor agreement existed between patients and caregivers across all pain lev-
els, perception of pain control and effectiveness of pain management. Specifically for 
chronic pain, poor agreement was noted between patients and caregivers (kappa=0.04; 
29% agreement) and patients and providers (kappa=−0.07; 21.4% agreement). Among 
patients reporting acute or chronic pain, only 67% and 43%, respectively, utilized med-
ication for their specific pain. Patients used more opioid medications than expected by 
their providers. On average, AYAs reported initial use of pain medications for chronic 
pain at 11.5 years.
Conclusions: Ongoing research is needed in haemophilia and VWD pain management, 
and on the differences in pain perception between patients, caregivers and providers. 
As chronic pain often begins at an early age, optimal pain management should include 
acknowledging patient complaints, exploring pharmacologic and non- pharmacologic 
options, and optimizing prophylaxis.
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1  | INTRODUCTION
Recurrent bleeding in patients with bleeding disorders may contrib-
ute to progressive joint damage and debilitating joint conditions and 
results in pain by early adulthood, emphasizing the importance of 
initiating prophylactic factor replacement therapy at an early age in 
patients with severe disorders.1,2 Differentiating between acute and 
chronic pain is crucial for determining proper therapeutic strategies. 
Multiple sources in the literature as well as anecdotal evidence from 
haemophilia professionals indicate that patients struggle to distinguish 
between acute pain and persistent daily pain.3-5 Since nearly 40% of 
patients with moderate or severe haemophilia in one study also in-
dicated their pain was not well treated,3 ongoing research is needed 
to identify specific areas of focus to improve pain management for 
patients.
Pain perception is complex and highly individualized, often depen-
dent on diverse physical, emotional, cultural and social factors. The ab-
sence of validated pain assessment scales for haemophilia has further 
contributed to the lack of understanding in this population.6 Equally 
important are caregiver and provider perceptions of pain. Caregivers 
(ie parents) often are the primary source of pain assessment in chil-
dren, although evidence suggests their assessments are not always ac-
curate.7The gold standard and primary source for identification of pain 
is the patient.8,9 Provider assessments often underestimate patients’ 
pain, especially in those with moderate to severe levels of pain.10-12 
Differences in perception and communication that exist between pa-
tients, caregivers and providers surrounding pain and pain manage-
ment may influence therapeutic decision- making and, subsequently, 
patient outcomes.
Despite the clinical significance of pain in bleeding disorders, 
scarce data exist to describe pain perception among patients, caregiv-
ers and providers. The goal of this study was to investigate agreement 
and differences in the perception of pain and pain management be-
tween adolescents and young adults (AYAs) with haemophilia or von 
Willebrand disease (VWD) and their caregivers and haemophilia treat-
ment centre (HTC) providers.
2  | MATERIALS AND METHODS
2.1 | Study population and recruitment
Data for this study were obtained from the larger study, the 
Interrelationship Between Management of Pain, Adherence to 
Clotting Factor Treatment, and Quality of Life (IMPACT QoL).13 For 
this study, we evaluated the perception of agreement between pa-
tients, caregivers and providers regarding pain, treatment of pain 
and perception of pain control. Eligible participants were aged 13- 
25 years; able to read, write and speak English; had haemophilia A 
or B, or VWD; and provided written consent (parental consent if 
<18 years). Recruitment occurred at major haemophilia conferences, 
including the annual National Hemophilia Foundation meeting, state 
consumer meetings, and inhibitor summits and through a Facebook 
page dedicated to this study from April 2012 to December 2012. 
All surveys were completed via Survey Monkey (Palo Alto, CA) on- 
site using Apple iPads (Cupertino, CA). The Munson Medical Center 
Internal Review Board (Traverse City, MI) approved the study. 
Significant others (ie a parent, wife, husband or live- in partner) were 
generally present with the participant and completed a similar survey. 
The participant or adult caregiver identified their HTC provider and 
signed a release form. This signed release allowed the surveyors to 
contact the HTC provider and allowed that provider to complete an 
online survey matched to the patient. All data were matched from par-
ticipant to caregiver and HTC provider and were de- identified (other 
than to the statistician) to maintain anonymity. E- mail reminders were 
sent to HTC staff members who did not respond to the initial request.
2.2 | Measurements
2.2.1 | Acute and chronic pain
Pain was measured via the Faces Pain Scale–Revised (FPS- R), which 
comprises six faces illustrating pain intensity: no pain (0), mild pain 
(2- 4), moderate pain (5- 6), severe pain (7- 8), very severe pain (9) 
and worst pain possible (10).14 Reliability and validity of the FPS- R 
are established from as young as 6 years up to adults. Pain questions 
were divided into two separate sections, one for acute and one for 
chronic/persistent. Acute was described as, “When you are having a 
bleed, what is your average or usual pain level? This is the type of pain 
you would have if you were to hurt yourself and bleed into a joint.” 
Chronic/persistent was described as “pain that you have every day or 
almost every day, and that always or almost always seems to be there 
even when you are not having a bleed at that moment.” Specific ques-
tions aimed to identify the following: level of acute and chronic pain; 
perception of pain control; effectiveness of pain management strate-
gies; need for more pain medication than prescribed or more often 
than prescribed; and how well providers listened to the participants 
regarding pain issues.
2.2.2 | Medications and non- pharmacologic 
interventions
Additional questions were asked regarding pharmacologic and non- 
pharmacologic methods used to manage pain and how well provid-
ers and caregivers helped to manage their pain. For each medication, 
patients and caregivers were asked separately if the patient ever used 
the medication for acute and/or chronic pain management; providers 
were not asked to make a distinction between acute and chronic pain 
with regard to prescribed pain medications. Medications were then 
divided into seven subcategories to aid in interpretation.
Patients, caregivers and providers were asked about the frequency 
of the patient using or (in the case of the provider) recommending 24 
different non- pharmacologic interventions (eg exercise, ice) for pain. 
Patients and caregivers were also asked about the patient’s use of 
alcohol, marijuana and illegal drugs other than marijuana. While the 
patient survey distinguished between acute and chronic pain for 
each of the non- pharmacologic interventions, caregiver and provider 
854  |     LAMBING et AL.
survey questions did not make this distinction for non- pharmacologic 
interventions. Therefore, both possible scenarios were evaluated and 
are referred to as “assuming acute” and “assuming chronic.” Rest, ice, 
compression, and elevation (RICE) were also compared with non- 
RICE interventions. Other self- reported data included information 
about participants’ age, sex, self- reported race/ethnicity, health insur-
ance status/type and educational levels of the participants’ parents. 
Additionally, data were collected regarding bleeding disorder type 
(haemophilia A or B, or VWD), presence of inhibitor and bleeding dis-
order severity (mild, moderate or severe).
2.3 | Statistical analysis
Agreement between patient and caregiver, patient and provider, and 
caregiver and provider responses was evaluated using the kappa 
statistic and percent agreement (Stata 14.1; StataCorp LP, College 
Station, TX). Agreement was rated as poor (kappa<0.2), fair (0.2- 0.39), 
moderate (0.4- 0.59), good (0.6- 0.79) or very good (0.8- 1.0). When the 
distribution of scores was not similar between groups and the majority 
of ratings were rank- order data, Spearman’s Rho was used to evaluate 
between- group correlations.
3  | RESULTS
Eighty- nine patient surveys were completed, with a correspond-
ing survey by either a caregiver (39%), provider (14%) or both 
(47%). Eight Health Resources and Service Administration regions 
plus Puerto Rico were represented, with the largest representation 
from the Great Lakes region. Providers included physicians (26%), 
nurse practitioners and physician assistants (30%) and nurses (44%). 
Patients were primarily White males, and the majority had haemo-
philia A (Table 1). Forty- five surveys evaluated the triad of patient, 
caregiver and provider.
Overall, kappa on all measures ranged from poor to moderate in 
each area evaluated: perception of pain and use of pharmacologic and 
non- pharmacologic interventions (Figures 1-3). Percent agreement on 
individual measures ranged from 21% to 100%.
3.1 | Pain agreement
Acute pain was reported as at least 4/10 by 55% of patients, while 
chronic pain was reported as at least 4/10 by 40% of patients. 
Agreement between patients and caregivers (providers were not 
queried about acute pain) on pain ratings during acute bleeding 
pain episodes was fair (Figure 1; kappa=0.27; 42.9% agreement), 
with patients more likely to report milder pain intensity than car-
egivers and the highest percentage of patients (29.2%) reporting 
moderate pain during a bleeding event (Figure 4A). Acute pain 
levels were positively correlated between patients and caregivers 
(Rho=0.49, P<.01).
There was poor agreement on chronic pain between patient and 
caregiver (kappa=0.04; 29% agreement) and patient and provider 
(kappa=−0.07; 21.4% agreement) (Figure 1). While no patients re-
ported a total absence of chronic pain (0/10), nearly 30% of caregivers 
and more than 47% of providers believed patients had a total absence 
of chronic pain (0/10) (Figure 4B). Providers also documented the 
patients’ reported average chronic pain level at previous office vis-
its as 0/1, or no chronic pain (51%; as reported by the patient to the 
provider during their office visit). Conversely, while 20% of patients 
reported very severe/worst possible chronic pain (8/10- 10/10), only 
6% of caregivers and no providers perceived the patient experienced 
chronic pain at that level, and none (0%) was reported during previous 
office visits.
The patient’s average chronic pain level was positively correlated 
with acute pain level during a bleeding event (Rho=0.49; P<0.01), in-
dicating that high chronic pain was reported with high acute pain, and 
conversely, low chronic pain was reported with low acute pain. Both 
the provider assessment of chronic pain and provider documentation 
TABLE  1 Patient demographics and clinical characteristics
Parameter, n (%) Patients (N=89)
Age, years
13–17 47 (53)
18–25 42 (47)
Sex
Male 75 (84)
Female 14 (16)
Race
White 63 (71)
Non- Whitea 26 (29)
Type of health care provider
Physician 14 (26)
NP/PA 16 (30)
RN/BSN/MSN 24 (44)
Primary bleeding disorder
Haemophilia A 66 (74)
Haemophilia B 8 (9)
Von Willebrand disease 15 (17)
Type 1 9 (10)
Type 2 2 (2)
Type 3 4 (4)
Haemophilia severity
Mild 9 (53)
Moderate 1 (6)
Severe 7 (41)
Inhibitor to factor/history of inhibitor
Yes 32 (36)
No 53 (60)
Did not know 4 (4)
aMost (16%) non- White respondents were Black/African American, 3% 
were of mixed race, and 1% were Asian. Not all respondents answered all 
questions.
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of patient- reported chronic pain were positively correlated with pa-
tient reports of acute pain (Rho=0.33 for both; P=0.057) but not with 
patient reports of chronic pain levels.
Patients, caregivers and providers were asked if the patient was 
in control of their pain or whether pain was controlling the patient 
(Table 2). Approximately two- thirds of patients, caregivers and provid-
ers felt the patient was in control of their pain. In 36% of patients, 31% 
of caregivers and 35% of providers, pain was reported to be in control 
of the patient or they were unsure.
When asked to rate the providers’ listening skills regarding pain 
issues, only fair agreement was noted between patients and provid-
ers (Figure 1; kappa=0.25, 42.59% agreement; Table 2). Patients re-
ported a wider range of provider listening than did providers. In 18% 
of patients, provider listening was rated as poor or fair compared with 
11% of providers who rated their listening as fair. No provider rated 
their listening as poor. Only 24% of providers rated their listening as 
excellent compared with 39% of patients who felt their provider had 
excellent listening.
3.2 | Medication agreement
When the provider was asked, “What treatments, other than pain medi-
cine, have you prescribed or recommended for pain management for 
your patient?” All respondents recommended factor. A large major-
ity of caregivers (90%) reported that patients utilized factor, but they 
were not asked to differentiate between use for chronic vs acute pain; 
patients self- reported utilizing factor for both acute pain (93%) and, to 
a slightly lesser extent, chronic pain (81%).
The average number of subcategory medications used for acute 
pain was 1.98 and chronic pain was 2.57. However, one patient ac-
knowledged having tried 12 of the 19 medications options for chronic 
pain and 17 for acute pain. Although approximately one- third of pa-
tients, caregivers and providers did not feel the patient was in control 
of their pain, fewer believed patients either needed (or took) more 
medication than prescribed. Fewer caregivers than patients (15% 
vs 26%) felt the patient needed more medication than prescribed 
compared with providers, who believed 14% of patients took more 
medication than prescribed. In comparison, 26% of both patients and 
caregivers felt medication was needed more often than prescribed, 
while providers felt 11% of patients took pain medication more often 
than prescribed. The agreement between individual patients and pro-
viders on this measure was poor (kappa=0.00 for more medication and 
0.09 for medication more often), and was only fair between patient 
and caregiver (kappa=0.23 for more medication, 0.08 for medication 
more often).
While 100% of patients reported acute pain, only 67% reported 
utilizing acute pain medication. Only 43% (20/47 patients) who indi-
cated they have chronic pain reported utilizing chronic pain medica-
tions. The average age at which patients began taking medications for 
chronic pain was 11.5 years.
The most common medications patients reported using for acute 
pain were factor and acetaminophen, and for chronic pain were factor 
and non- steroidal anti- inflammatory drugs (Figure 2). With regard to 
short- acting opioids, patients reported a higher rate of use for chronic 
pain compared with providers (21% vs 13%). The same was seen for 
long- acting opioids in chronic pain use (patients 11% vs providers 6%). 
F IGURE  1 Agreement (Kappa) on perceptions of pain and pain management. Agreement was rated as poor (<0.2), fair (0.2- 0.39), moderate 
(0.4- 0.59), good (0.6- 0.79) or very good (0.8- 1.0). CG, caregiver; PROV, provider; PT, patient
–0.2 –0.15 –0.1 –0.05 0 0.05 0.1 0.15 0.2 0.25 0.3
Pain level when having a bleed
Chronic pain level
Perception of pain control
Need for more medication than prescribed
Effectiveness of pain management
Patient need for more medication than prescribed (PT/CG)/provider believes 
patient takes more medication than prescribed (PROV)
Need for pain medication more often than prescribed
Need for pain medication more often than prescribed (PT/CG)/provider 
believes patient takes pain medication more often than prescribed
How well provider listens about pain issues
CG-PROV PT-PROV PT-CG
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The highest kappa values for agreement between patients and provid-
ers were on the use of short- acting opioids, assuming either acute or 
chronic pain, and factor, assuming acute pain.
3.3 | Non- pharmacologic treatment agreement
The 10 most frequent non- pharmacologic interventions used by pa-
tients are in Figure 3. Use of RICE vs non- RICE interventions was 
compared between patient report, caregiver observation and provider 
prescription. Although patients used RICE often, they were also much 
more likely to use additional non- RICE methods for either acute (chi 
square=92.36; P<.0001) or chronic (chi square=65.76; P<.0001) pain 
than specifically prescribed by providers. The most frequently used 
non- RICE methods reported by patients were diversional activities, 
such as: watching movies or television, thinking about something else, 
video games, telling jokes, deep breathing and exercise. Although not 
recommended by providers, alcohol (acute, 9%; chronic, 14%), mari-
juana (acute, 11%, chronic, 14%) and illegal drugs (acute, 1%; chronic, 
4%) were used by patients for both chronic and acute pain.
4  | DISCUSSION
The factors that influence pain perceptions in the bleeding disorders 
community among patients, caregivers and practitioners are complex 
and multifactorial. However, a greater understanding of how these 
groups describe pain and select therapies for acute and chronic pain is 
critical to improving the clinical management of bleeding disorders. To 
date, data on pain perceptions in these groups are limited. The results 
of this survey demonstrate that there is dissonance among patients, 
caregivers and providers regarding the perception of pain and the ef-
fectiveness of pain management.
Specifically, our findings show there is poor agreement between 
patients and caregivers across all levels of pain, perception of pain con-
trol and effectiveness of pain management. Of note, there was poor 
agreement between patient and both caregiver and provider on the 
level of chronic pain, whereas fair agreement was observed between 
caregivers and providers. It is possible that patients may self- report 
pain more frequently in an anonymous survey than during an office 
visit with their health care provider, leading to some of the noted 
F IGURE  2 Agreement (kappa) on medications used for acute and chronic pain. Patients and caregivers reported use of medications for 
both acute and chronic pain management. Providers did not provide a distinction between acute and chronic pain; therefore, agreements are 
assessed by assuming acute and assuming chronic. No distinction was made between acute and chronic pain on the caregiver survey for factor 
use; therefore, caregiver agreements are assessed by assuming acute and assuming chronic. Agreement was rated as poor (<0.2), fair (0.2- 0.39), 
moderate (0.4- 0.59), good (0.6- 0.79) or very good (0.8- 1.0). CG, caregiver; PROV, provider; PT, patient
Adjuvants
Non-opioids
Short-acting opioids
Long-acting opioids
NSAIDs
Factor
Acetaminophen
–0.4 –0.2 0 0.2 0.4 0.6 0.8 1
PT-CG (assuming chronic) PT-CG (assuming acute) CG-PROV (assuming chronic)
CG-PROV (assuming acute) PT-PROV (assuming chronic) PT-PROV (assuming acute)
PT-CG (chronic) PT-CG (acute)
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misperceptions. Anecdotally, patients have told providers that, while 
they do experience chronic pain, they will not let anyone know the de-
gree of their discomfort as this may result in further limitations to ac-
tivity, and this may be a reflection of that observation. Patients should 
be encouraged to speak candidly with their caregivers and providers 
regarding their pain and the effectiveness of their pain management.
Although not specific to bleeding disorders, the literature demon-
strates the influence of caregiver and provider perceptions on patient 
pain. From the caregivers’ perspective, parents who experienced more 
of their own pain conditions and who were treated more frequently for 
pain encouraged pain expression in their adolescents and were more 
likely to catastrophize their adolescent’s pain symptoms.15 From the 
providers’ perspective, “pain miscalibration,” or the difference between 
the physician’s pain rating and the patient’s pain rating, has been re-
ported.16 Chronicity also affects pain miscalibration among provid-
ers, with chronic pain viewed as being less severe than acute pain.12 
Additionally, the manner in which patients display their pain influences 
provider assessment and pain medication dosing.17 Thus, the level of 
pain reported may be influenced by many factors and often varies be-
tween patients, caregivers and providers. The average level of acute 
and chronic pain reported by the participants in the current survey was 
similar to those previously reported.5,17 These observed differences 
in pain perception between patients, providers and caregivers under-
score the need for continual education on pain perceptions and the 
recognition of poor communication between these parties.
Despite 33% of acute pain patients and 57% of chronic pain pa-
tients not using medications for their specific pain, this survey analysis 
revealed patients are still using more opioid medication than expected 
by providers. Although HTC prescribers provide the majority of care, 
nearly one- third of patients are receiving their pain medications from 
their primary care provider or from other sources.3,4 Given the dis-
crepancy between patient and provider reports of chronic pain, it is 
F IGURE  3 Agreement (kappa) on top 10 patient- reported non- pharmacologic interventions used for management of acute and chronic 
pain. Patients reported using interventions for both acute and chronic pain management. Caregivers and providers did not provide a distinction 
between acute and chronic pain; therefore, agreements are assessed by assuming acute and assuming chronic. Agreement was rated as poor 
(<0.2), fair (0.2- 0.39), moderate (0.4- 0.59), good (0.6- 0.79) or very good (0.8- 1.0). CG, caregiver; PROV, provider; PT, patient
–0.2 –0.1 0 0.1 0.2 0.3 0.4 0.5
Rest/sleep
Ice
Ace wrap
Elevation
Watch movies/television
Thinking about something else
Video games
Tell jokes
Deep breathing
Exercise
CG (assuming acute)PT-
PT-CG (assuming chronic)
PT-PROV (assuming acute)
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possible that some patients may be obtaining opioid medication from 
other providers, without informing their HTC provider. There are also 
patients with excellent adherence and good rapport with their pro-
viders who may believe they need more medication, but who actually 
do not seek to take more medication. This survey did not elicit the 
reasons driving these different behaviours in patients.
Among the participants surveyed, the average age at which pa-
tients began taking medication for chronic pain was 11.5 years, sug-
gesting prophylaxis to control bleeding events may be suboptimal 
or treatment adherence is lacking.13 As expected, providers strongly 
encouraged factor replacement as a treatment strategy for acute 
pain associated with a bleed. For acute pain management, the AYA 
F IGURE  4 Perception of acute and 
chronic pain during bleeding events. 
Patients and caregivers reported their 
perception of acute pain (A); providers 
were not queried about acute pain. 
Patients, caregivers and providers reported 
their perceptions of chronic pain (B)
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5
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Provider (n = 55)
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Chronic pain level 
Mild Moderate Severe Very 
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possible
R
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ts
 (%
)
(A)
(B)
Variable, n (%)
Respondent 
reported (n=89)
Caregiver assessment 
(n=77)
Provider 
assessment (n=54)
Perception of pain control
Patient in control of 
pain
57 (64) 53 (69) 35 (65)
Not sure 20 (22) 6 (8) 14 (26)
Pain in control of 
patient
12 (14) 18 (23) 5 (9)
How well provider listens about pain issues
Poor 7 (8) – 0 (0)
Fair 9 (10) – 6 (11)
Well 14 (16) – 16 (30)
Very well 24 (27) – 19 (35)
Excellent 35 (39) – 13 (24)
TABLE  2 Perception of pain control 
and provider listening
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participants of this study followed that advice better than older adult 
participants in previous studies; however, the same cannot be said 
with regard to chronic pain. It was surprising that this age group con-
tinued to report pain despite the use of ongoing prophylaxis of factor 
replacement from an early age, underscoring the importance of ad-
herence and optimal dosing to minimize breakthrough bleeding which 
leads to acute and thus chronic pain.2-4 Compared with 58% of adults 
who use factor for chronic pain in the National Pain Study,3 81% of 
AYAs in this study use factor inappropriately for what they identify 
as chronic pain. Among AYAs with moderate or severe haemophilia, 
better adherence to prophylaxis is associated with a lower likelihood 
of having high levels of chronic pain.13 The current findings suggest a 
need for improved adherence to prophylaxis with prescribed clotting 
factor treatment regimens (either prophylactic or on demand), with the 
goal to eliminate bleeding events that result in chronic pain.
4.1 | Study limitations
When interpreting the results of this study, a few limitations should be 
considered. First, due to the small sample size of the analysed cohort, 
survey answers that were on a frequency scale (ie never, rarely, some-
times, often, always) were dichotomized for the comparative analysis 
on use of the medications and non- pharmacologic treatments. Direct 
comparisons of survey answers between patients, providers and car-
egivers were complicated because of differences in survey questions. 
For example, patients and caregivers were asked if they believed the 
patient needed pain medication more often and/or more frequently 
than prescribed, whereas the corresponding provider questions asked 
whether the provider believed the patient was taking more medica-
tion than prescribed, or if the patient was taking medication more 
often than prescribed. In addition, patients were not asked who pre-
scribed their pain medications. While the data suggest that patients 
were receiving more pain medication than their treating provider was 
aware of, there is no clear indication of the source of that medication 
from the survey. Further, providers were not asked to distinguish be-
tween acute and chronic pain for medication and non- pharmacologic 
treatments, and caregivers were not asked to distinguish between 
acute and chronic pain for non- pharmacologic treatments, limiting di-
rect comparisons. This study may also be limited by sampling bias, as 
patients active in the haemophilia community were more likely to par-
ticipate. Lastly, several of the baseline demographic data (ie bleeding 
order severity, history of inhibitors) were self- reported by the patients 
and were not confirmed with the providers.
5  | CONCLUSIONS
This study provides insight into the clinical management of pain in 
AYAs with haemophilia or VWD and how perceptions of pain man-
agement differ between patients, caregivers and providers. This is 
important because the average age of chronic pain was 11.5 years, 
suggesting that pain is an early and common aspect of the haemophilia 
disease ensemble. There appears to be a disconnect regarding chronic 
pain perception in that all patients reported chronic pain, while nearly 
30% of caregivers and more than 47% of providers thought chronic 
pain was absent. Based on the observation that medication use re-
ported by patients and providers differed, emphasis should be placed 
on listening to patients regarding their complaints of pain, exploring 
optimal pain management options to manage pain, and optimizing 
prophylaxis to minimize or eliminate bleeding events.
In previous surveys, haemophilia patients struggled to differenti-
ate between acute and persistent pain, selecting similar words to de-
scribe their pain experience, regardless of the type of pain, which may 
lead to a failure to select the most appropriate therapeutic option.3, 4 
Additionally, all patients in this analysis reported using factor to treat 
pain (93% acute, 81% chronic). Recent advances in point- of- care ultra-
sound for haemophilia may hold promise to assist providers and pa-
tients in distinguishing between chronic arthropathic pain (treatment 
with analgesics not factor) and chronic pain due to a prolonged bleed-
ing event (extended treatment with factor).18
At every visit, providers should also perform medication reconcilia-
tion to understand patient medication history and currently prescribed 
pain medications. Providers should continue to make greater efforts 
to discuss patient pain levels, rather than assume an absence of pain if 
not articulated by the patient, who may accept pain as routine.
Further studies on differences in the perception of pain manage-
ment in bleeding disorders between patients, caregivers and providers 
that include a wider age range of patients and a larger sample size are 
warranted to support the findings of this initial analysis.
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